↓ Skip to main content

Cochrane Database of Systematic Reviews

Flupenthixol versus placebo for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 X users
weibo
1 weibo user
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
108 Mendeley
Title
Flupenthixol versus placebo for schizophrenia
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd009777.pub2
Pubmed ID
Authors

Xiaohong Shen, Jun Xia, Clive E Adams

Abstract

Flupenthixol, first made available in the UK in 1965, has been used as a treatment for schizophrenia for decades.

Timeline
X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
South Africa 1 <1%
Unknown 106 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 15%
Student > Ph. D. Student 11 10%
Student > Bachelor 11 10%
Researcher 10 9%
Student > Doctoral Student 8 7%
Other 20 19%
Unknown 32 30%
Readers by discipline Count As %
Medicine and Dentistry 30 28%
Psychology 14 13%
Nursing and Health Professions 9 8%
Agricultural and Biological Sciences 3 3%
Social Sciences 3 3%
Other 14 13%
Unknown 35 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2023.
All research outputs
#5,271,170
of 25,850,671 outputs
Outputs from Cochrane database of systematic reviews
#7,411
of 13,147 outputs
Outputs of similar age
#36,905
of 193,597 outputs
Outputs of similar age from Cochrane database of systematic reviews
#140
of 243 outputs
Altmetric has tracked 25,850,671 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,147 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.5. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,597 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 243 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.